Filter
1504
Filtered Results: 1504
Text search:
vaccine
trial
Featured
Recommendations
178
New Publications
333
Language
Document type
No document type
662
Studies & Reports
289
Guidelines
257
Manuals
93
Fact sheets
74
Strategic & Response Plan
64
Situation Updates
20
Training Material
17
Resource Platforms
12
Infographics
7
Videos
6
Brochures
2
App
1
Countries / Regions
Global
75
India
43
Sierra Leone
35
Liberia
35
Kenya
34
Nigeria
29
South Africa
28
Ethiopia
24
Western and Central Europe
22
Uganda
21
West and Central Africa
20
Latin America and the Carribbean
19
East and Southern Africa
18
Brazil
18
Africa
17
Guinea
16
Congo, Democratic Republic of
15
Russia
14
Ukraine
13
Ghana
13
Zambia
13
Rwanda
12
Bangladesh
12
Eastern Europe
12
Tanzania
11
Nepal
10
Malawi
10
Mozambique
10
Germany
10
South Sudan
10
Syria
9
Zimbabwe
9
Philippines
9
Cambodia
9
South–East Asia Region
9
Myanmar / Burma
9
Middle East and North Africa
8
Namibia
7
Senegal
6
Asia
6
Burkina Faso
5
Eastern Europe and Central Asia
5
Vietnam
5
Lesotho
4
Haiti
4
Central African Republic
4
Botswana
4
Indonesia
4
Thailand
3
China
3
Chile
3
Cameroon
3
Laos
3
USA
3
Paraguay
3
United Kingdom
3
Lebanon
3
Yemen
3
Angola
3
Turkey
2
Peru
2
Guinea-Bissau
2
Venezuela
2
Jordan
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Papua New Guinea
2
Sudan
2
Chad
2
Madagascar
2
Tajikistan
1
Mexico
1
El Salvador
1
Benin
1
Gambia
1
Iran
1
Albania
1
Kyrgyzstan
1
Niger
1
Malaysia
1
Morocco
1
Bulgaria
1
Italy
1
Western Pacific Region
1
Gabon
1
Japan
1
Denmark
1
France
1
Tunisia
1
Portugal
1
Southern Africa
1
Moldova
1
Honduras
1
Mali
1
Iraq
1
Somalia
1
Ecuador
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
431
Clinical Guidelines
172
Women & Child Health
79
Public Health
74
Key Resources
41
Pharmacy & Technologies
21
Capacity Building
8
Toolboxes
COVID-19
320
HIV
112
TB
112
Ebola & Marburg
85
NTDs
74
AMR
61
Rapid Response
60
Pharmacy
35
Malaria
32
Mental Health
26
Health Financing Toolbox
24
Global Health Education
22
Planetary Health
21
Conflict
21
Refugee
19
Caregiver
16
NCDs
14
Cholera
13
Polio
13
Zika
12
Natural Hazards
5
Disability
5
Specific Hazards
4
In the current absence of vaccine for COVID-19, public health response target breaking the chain of infection by focusing on the mode of transmission. This paper summarizes current evidence-base around the transmission dynamics, pathogenic, and clinical features of COVID-19, to critically identify i...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Immunization in the context of COVID-19 pandemic
recommended
Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood of a VPD outbreak decreases
This publication is available in Arabic, Chines...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Tackling COVID-19 misinformation. Ensuring communities have access to lifesaving public health information from trusted sources and are not misled by misinformation is essential to ending the COVID-19 pandemic.
In an effort to empower doctors and nurses – some of the most effective and trusted...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
The WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination is intended to offer guidance on the prioritization of groups for vaccination when vaccine supply is limited. It provides a values foundation for the objectives of COVID-19 vaccination programmes and links t...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
Update 2021; Immunization, Vaccines and Biologicals
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their income level and allocation of domestic resources to medicine and vaccine procurement. Access to safe a...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
COVID-19 Vaccination & Communication
recommended
March 9, 2021
Here you can find a collection of useful manuals, videos, infographics and resource platforms.
The category "Vaccine hesitancy & myths" will be updated regularly with new documents, videos and information material. Please check this category within the COVID-19
https://medbox.org/fi...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Breakthrough innovations have come to light that have proved to be more than 95% effective in preventing HIV infection with injections just twice a year. Once a year might even be possible. They could also be key for 40 million people living with HIV around the world who need better options for trea...
